Dermatology: Atopic Dermatitis Flashcards

1
Q
  1. What is CAD?
  2. How is it diagnosed?
A

Genetically predisposed inflammatory and pruritic allergic skin disease
Allergens include house dust mites, pollen mol spores

Some cases have no detectable allergens- environmental and/or food

History, Clinical signs, exclusion of differentials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the pathogenesis of CAD?

A
  1. Cutaneous inflammation and pruritus
  2. Defective skin barrier function
  3. Microbial colonization- staph
  4. Other flare factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What inflammatory reactions cause CAD?

A

Type I hypersensitivity
* IgE bound to mast cells
* Allergen bound by IgE
* Products of mast cell degranulation cause inflam and prutitus

Type IV hypersensitivity
* Allergen peptides presented to T-cells by langerhands
* T-cells produce pro-inflam cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What commonly causes flares of CAD?

A
  • Bacteria and yeast secondary infection
  • Increase in allergen through seasonal changes
  • Fleas, scabies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a compatible history of CAD?

A
  • Pruritus seasonal or perennial or both- precedes skin lesions
  • Certain breeds
  • Pruritus main clinical sign
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the secondary skin lesions of CAD?

A

Otitis
Pruritic lesions
* Alopecia
* Excoriations
* Salivary staining
* Lichenification
* Pusutles
* Hyperpigmentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the distribution of CAD?

A
  • Face and chin
  • Periorbital
  • Ears- not the margins
  • Elbow creases
  • Feet
  • Ventral abdomen
  • Perianal area
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are favrots criteria for CAD?

A
  1. Onset of signs < 3y
  2. Dog living mostly indoors
  3. Glucocorticoid responsive prutitus
  4. Alesional pruritus
  5. Affected front feet and/or pinnae
  6. Non-affected ear margins
  7. Non-affected dorso-lumbar area
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are differentials for CAD?

A
  • Ectoparasites- mites
  • Microbial infection- from another problem
  • Malassezia dermatitis
  • Cheyletiellosis- dorsal
  • Contact dermatitis- location/distribution
  • Pemiphigus foliaceus- pustules before irritation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How are ectoparasites exluded?

A
  • In house tests- wet paper, skin scrapes
  • Treatment trials for environmental- fleas/scabeis- flurolaner
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How are secondary infection overgrowths diagnosed?

A

Cytology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the most common food allergens?

A

Beef, lamb and milk

Home cooked diet trials are gold standard

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How long should food trials be done?

A

Minumum of 6 weeks- better if 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What drugs should be given for first 2-3 weeks of food trial?

A

Steroids or oclacitinib

Reduce secondary inflammation
Comfortable animal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What can be used in addition for food trials for managment of CAD?

A

Environmental allergen testing
* Identified environmental allergen-specific IgE for use in managment
* Ensure excluses differentials

mites, pollens, fungi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the aims for treatment of CAD?

A
  • Improve skin barrier
  • Allergen avoidance and ASIT
  • Control inflammation and pruritis
  • Control flare factors
17
Q

How is skin barrier function improved?

A
  • Non-irritating shampoos
  • Topical moisturisers and emollients
  • Supplementation with oral EFAs
  • Application of topical EFA-containing formulations
18
Q

How can allergies be avoided?

A
  • Close windows during peak season- pollen
  • Restrict going outdoors
  • Aeration at night/early mroning
  • Avoid exposure to risk situations- lawn mowing
18
Q

How can allergies be avoided?

A
  • Close windows during peak season- pollen
  • Restrict going outdoors
  • Aeration at night/early mroning
  • Avoid exposure to risk situations- lawn mowing
19
Q

What is AIT?

A

Allergen immunotherapy

Gradual increases of allergen extract to ameliorate the symptoms

20
Q

What anti-inflammatory and anti-pruritic therapies can be given?

A

Glucocorticoids
* systemic- prednisolone
* topical- betmethasone

Calcineurin inhibitors- ciclosporin
Janus Kinase inihibitor
Oclacitinib
Biologics
Antihistamines

21
Q

When are systemic glucocorticoids indicated?

A

Flare controlling

22
Q

What is the function of ciclosporin and the adverse effects?

A

Inhibits T lymphocyte function via blocking calcineurin

Adverse
* GI signs
* Gingival hyperplasia
* Viral papillomas
* Hirsuitism- hair growth

23
Q

What is used for Janus Kinase inhibitor?

A

Oclacitinib

> 12mo >3kg

23
Q

What is used for Janus Kinase inhibitor?

A

Oclacitinib

> 12mo >3kg

24
Q

What is the action of lokivetmab (cytopoint)

A

Caninised monoclonal antibody that specifically targets and neutralises canine IL-31- pruritogenic cytokine

25
Q

What is used for induction of remission of CAD?

A
  • Oral and topical glucocorticoids
  • As reduced use oclacitinib
26
Q

How is prevention of reccurence of CAD treated?

A

Allergen avoidance ± immuotherapy
* Lokivetmab
* If worsens- ciclosporin
* If severe- oral ± topical glucocorticoids

27
Q

How can flare factors be controlled?

A
  • Stress- adaptil
  • Envionment- irritants, temp
  • Foods- allergens, histamine releasing
28
Q

How often should CAD be reassesed?

A

Assess every 2-6 weeks until stable

Once stable continue to reassess- 6-12m

29
Q

How can CAD treatment be tailored?

A
  • Chronicity- how well are signs managed
  • Distirbution
  • Seasonality
  • Secondary infection risk
  • Adverse side effects
  • Concurrent disease
  • Response to previous therapy
  • Owner preferences- cost, ease